FdaApplication

ANDA 218640

Back to search

Identifiers

Properties

PropertyValue
applicant_nameASCENT PHARMACEUTICALS INC
application_typeANDA
approval_date2025-01-02

Products (2)

ProductActive ingredientStrengthDosage form
LUBIPROSTONELUBIPROSTONE24MCGCAPSULE;ORAL
LUBIPROSTONELUBIPROSTONE8MCGCAPSULE;ORAL

2 products